Polar Capital Holdings plc ("Polar Capital" or "the Group")
Interim results for six months ended 30 September 2014
11 December 2014
Financial Highlights
· Assets under Management ("AUM") at 30 September 2014 up 1% to US$13.4bn (31 March 2014: US$13.2bn)
· Core operating profit, excluding performance fees, up 34% to £13.9m (30 September 2013: £10.4m)
· Profit before share-based payments of £12.7m (30 September 2013: £10.6m)
· Pre-tax profit of £11.6m (30 September 2013: £10.1m)
· Basic earnings per share 10.55p (30 September 2013: 9.53p) and adjusted* diluted earnings per share 10.75p (30 September 2013: 8.77p)
· Interim dividend per ordinary share of 5.5p declared (2013: 4.0p) to be paid in January 2015 (see comment in CEO's report on dividends)
· Shareholders' funds of £65.5m (31 March 2014: £74.2m and 30 September 2013:£56.8m) including cash and investments of £63.4m (31 March 2014: £90.9m and 30 September 2013:£56.7m)
* Adjusted to exclude cost of share-based payments
Corporate Highlights
· Launch of three new funds since 31 March 2014
o Long only Healthcare Blue Chip UCITS Fund launched in September 2014
o UK Absolute Equity UCITS fund launched in September 2014
o Long only European Income UCITS fund launched in October 2014
Current Trading
· AUM at 30 November 2014 were US$13.2bn
· Accrued performance fee profits (marked to market) at 30 November 2014 were £4.2m
Tim Woolley, Chief Executive Officer, commented:
"The first six months of our financial year have been challenging. Since 31 March 2014 we have seen growth in Assets under Management across most portfolios but this has been offset by outflows from Japan. The success of our Japan team over recent years has led in the short-term to our AUM being unusually sensitive to the direction of and allocations to the Japanese market which suffered a reversal in the first six months of our new financial year.
Over the shorter term our results will continue to be influenced by events in Japan and allocations to or away from our Japanese funds. However, we continue to invest in the business for the longer term and have added two new teams during our first half. We remain optimistic on the longer term opportunities for the business and see considerable scope for many of the other strategies beyond Japan to grow substantially in time."
For further information please contact: |
||||||||||||||||||||||||
|
Polar Capital Holdings plc is a specialist investment management company offering professional and institutional investors a range of fundamentally research-driven funds diversified by asset class, geographical and sectoral specialisation. Since its foundation in 2001, the Group has steadily grown and currently supports 11 investment teams managing 22 funds (23 funds at the end of November 2014) and six managed accounts across a range of long-only and alternative products.
Polar Capital Holdings plc was listed in London on the Alternative Investment Market in February 2007 and it trades under the ticker 'POLR.LN'.
Consistent with Polar Capital's founding strategy of fostering an equity culture amongst its staff and providing a high level of transparency to clients, 36% of the equity is held by directors, founders and staff. Polar Capital is principally located in London and maintains offices with investment staff in Edinburgh, Tokyo, Connecticut, Jersey and Geneva.
Our Funds/Strategies
(In chronological order)
Assets Under Management |
30 September 2014 US$m |
31 March 2014 US$m |
30 September 2013 US$m |
Technology |
1,898 |
1,793 |
1,488 |
Technology Trust plc |
1,128 |
1,043 |
923 |
Global Technology UCITS Fund |
770 |
750 |
565 |
Japan |
5,301 |
5,629 |
4,914 |
Japan UCITS Fund* |
5,158 |
5,478 |
4,861 |
Japan Alpha UCITS Fund |
143 |
151 |
53 |
Europe |
771 |
761 |
704 |
European Forager Alternative Fund |
613 |
602 |
548 |
European Conviction Alternative Fund |
158 |
159 |
156 |
Healthcare |
1,170 |
1,184 |
794 |
Global Healthcare Growth & Income Trust plc |
324 |
321 |
252 |
Healthcare Opportunities UCITS Fund |
804 |
854 |
542 |
Biotechnology UCITS Fund |
15 |
9 |
- |
Healthcare Blue Chip UCITS Fund |
27 |
- |
- |
Financials |
979 |
1,063 |
975 |
Asian Financials UCITS Fund |
48 |
46 |
55 |
Global Insurance UCITS Fund |
471 |
582 |
559 |
Income Opportunities UCITS Fundj |
131 |
106 |
90 |
Financial Opportunities UCITS Fund |
28 |
27 |
24 |
Global Financials Trust plc |
301 |
302 |
247 |
Global Emerging Markets |
972 |
832 |
749 |
Emerging Markets Growth UCITS Fund* |
243 |
303 |
291 |
Emerging Markets Income UCITS Fund |
729 |
529 |
458 |
Global Convertibles |
202 |
103 |
73 |
ALVA Global Convertible Fund* |
87 |
73 |
68 |
Global Convertible UCITS Fund |
115 |
30 |
5 |
North American UCITS Fund |
2,024 |
1,729 |
1,321 |
Global Alpha UCITS Fund |
95 |
85 |
33 |
UK Absolute Equity UCITS Fund |
10 |
- |
- |
Closed Strategies |
- |
70 |
357 |
Total |
13,422 |
13,249 |
11,408 |
j Previously Financials Income UCITS Fund, name changed in June 2014
*Including managed accounts run off the same strategy
Analysis of Changes in Asset Types for the six months to 30 September 2014
|
Long only Funds US$m |
Alternative Funds US$m |
Total US$m |
Total assets as at 31 March 2014 |
12,315 |
934 |
13,249 |
Net subscriptions/(redemptions) from ongoing business |
(425) |
117 |
(308) |
Closure of European Market Neutral team |
Nil |
(67) |
(67) |
Performance and currency movements |
549 |
(1) |
548 |
Total assets at 30 September 2014 |
12,439 |
983 |
13,422 |
Analysis of AUM by Business Unit and Type of Funds as at 30 September 2014
Technology |
14% |
|
Long only funds |
93% |
Japan |
39% |
|
Alternative funds |
7% |
Europe |
6% |
|
|
100% |
Healthcare |
9% |
|
|
|
Financials |
7% |
|
|
|
Global Emerging Markets |
7% |
|
|
|
Global Convertibles |
2% |
|
|
|
North American |
15% |
|
|
|
Global Alpha |
1% |
|
|
|
UK Absolute Equity |
- |
|
|
|
|
100% |
|
|
|
Chief Executive's Statement
The first six months of our financial year have been challenging. Although our assets under management (AUM) at 30 September 2014 were 17.5% above the level at 30 September 2013, the increase in AUM since 31 March 2014 has been just 1% with growth seen across most portfolios but offset by outflows from Japan. Consequently core profits of £13.9m for the six months to 30 September 2014, although a 34% increase over the comparable period in 2013 and derived from a relatively stable total AUM, are marginally below those for the six months to 31 March 2014 due to the mix of our business and the costs of ongoing investment in the Group.
|
Six months to 30 September 2014 |
Six months to 30 September 2013 |
Core operating profit |
£13.9m |
£10.4m |
Performance fee profit |
- |
- |
Finance expense/(income) |
£(1.2)m |
£0.2m |
Profit before share based payments and tax |
£12.7m |
£10.6m |
Adjusted diluted earnings per share (non GAAP measure) |
10.75p |
8.77p |
The majority of the Group's performance fees fall due at the end of December, so the lack of such fees at the half year is unsurprising. Whilst it is not possible to predict year end performance fee profits at both the half year point and 30 November 2014, on a mark to market basis, there were £4.2m of performance fee profits due to the Group.
The half year results include a finance expense of £1.2m. This revenue line is the sum of revenues/costs generated from balance sheet cash and investments and related hedging strategies. The investments are seed monies to support the Group's smaller and more recently launched funds. In the six month period £1.2m of mark to market losses were booked from hedging strategies taken out to reduce the market exposure on the long only investments. At 30 September 2014 there were £1.0m of matching unrealised profits on the same seed investments.
In the annual report the Board provided guidance to assist shareholders in forecasting and understanding the size of the Group's first interim dividend, paid in January. The Board confirmed that going forward the first dividend would be predicated on half of the first half year's core earnings. On this basis the dividend payment in January 2015 will be 5.5p (2014: 4p).
Investors should note that the increase in the January 2015 first interim dividend compared to 2014 should not be taken as any indication of the size of the final dividend that will be paid in July 2015. The Board will base its decision for the year's total dividend, and hence the level of the second dividend, on the core and performance fee earnings for the full year.
I cautioned at this stage last year that our growth rate would be likely to slow after the exceptional pace of previous years and so it has proved. The success of our Japan team over recent years has led in the short-term to our AUM being unusually sensitive to the direction of and allocations to the Japanese market which suffered a reversal in the first six months of our new financial year.
The strong inflows we had into a number of our other products including North America, Emerging Markets Income and Global Convertibles were insufficient to offset the outflows and market falls in Japan.
We continue to invest in the business and added two new teams during our first half - a UK Absolute team headed by Guy Rushton and a Pan European Income team headed by Nick Davis. Neither of these initiatives will have a material impact on our outlook in the near future although both have significant potential for growth over the medium and longer term.
In September, our award winning Healthcare team launched their fourth product the Healthcare Blue Chip Fund. This is a large cap healthcare fund and provides another outlet for the broad based capability of the team.
Since the end of our first half year, markets have been extremely volatile and we have seen a sharp recovery in the Japanese market following renewed and aggressive monetary stimulus from the Bank of Japan. This took many people by surprise but was consistent with the expectation of our Japan team. It is too early to predict the impact this will have on allocations to the Japanese market and our own fund offerings.
We remain optimistic on the longer term opportunities for the business and see considerable scope for many of the other strategies beyond Japan to grow substantially in time. However, over the shorter term our results will continue to be influenced by events in Japan and allocations to or away from our Japanese funds.
Tim Woolley
Chief Executive 10 December 2014
Interim Consolidated Income Statement for the six months to 30 September 2014
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
|
Revenue |
41,803 |
31,646 |
|
Finance (expense)/income |
(1,202) |
231 |
|
Gross income |
40,601 |
31,877 |
|
Commissions and fees payable |
(4,633) |
(2,363) |
|
Net income |
35,968 |
29,514 |
|
Operating costs before share-based payments |
(23,254) |
(18,878) |
|
Operating profit before share-based payments, amortisation/impairment and tax |
12,714 |
10,636 |
|
Share-based payments |
(1,122) |
(551) |
|
Profit for the period before tax |
11,592 |
10,085 |
|
Taxation |
(2,513) |
(2,365) |
|
Profit for the period attributable to ordinary shareholders |
9,079 |
7,720 |
|
Basic earnings per ordinary share |
10.55p |
9.53p |
|
Diluted earnings per ordinary share |
9.56p |
8.19p |
|
Adjusted diluted earnings per ordinary share (Non GAAP measure) |
10.75p |
8.77p |
|
All of the items in the above statements are derived from continuing operations.
Interim Consolidated Statement of Comprehensive Income for the six months to 30 September 2014
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
|
||
Profit for the period attributable to ordinary shareholders |
9,079 |
7,720 |
|
||
Other comprehensive income - items that may be reclassified to income statement in subsequent periods: |
|
|
|
||
Net gain on the revaluation of available-for-sale financial assets |
663 |
16 |
|
||
Deferred tax effect |
(133) |
- |
|
||
|
530 |
16 |
|
||
Net movement on the fair valuation of cash flow hedges |
(1,277) |
1,397 |
|
||
Deferred tax effect |
427 |
(354) |
|
||
|
(850) |
1,043 |
|
||
Other comprehensive income |
(320) |
1,059 |
|||
Total comprehensive income for the period, net of tax, attributable to ordinary shareholders |
8,759 |
8,779 |
|||
Interim Consolidated Balance Sheet as at 30 September 2014
|
(Unaudited) 30 September 2014 £'000 |
(Audited) 31 March 2014 £'000 |
|
||
Non-current assets |
|
|
|
||
Property, plant and equipment |
91 |
94 |
|
||
Deferred tax assets |
5,984 |
7,472 |
|
||
Total non-current assets |
6,075 |
7,566 |
|
||
Current assets |
|
|
|
||
Available-for-sale financial assets |
40,484 |
43,912 |
|
||
Trade and other receivables |
16,607 |
9,675 |
|||
Cash at bank |
22,962 |
47,041 |
|||
Other financial assets |
- |
654 |
|
||
Total current assets |
80,053 |
101,282 |
|
||
Total assets |
86,128 |
108,848 |
|||
Non-current liabilities |
|
|
|
||
Deferred tax Liabilities |
- |
221 |
|
||
Current liabilities |
|
|
|||
Trade and other payables |
14,947 |
29,484 |
|||
Other financial liabilities |
3,873 |
1,965 |
|||
Current tax liabilities |
1,823 |
3,008 |
|
||
Total current liabilities |
20,643 |
34,457 |
|
||
Total liabilities |
20,643 |
34,678 |
|||
Net assets |
65,485 |
74,170 |
|||
Capital and reserves |
|
|
|
||
Issued share capital |
2,207 |
2,184 |
|
||
Share premium |
16,656 |
16,288 |
|||
Investment in own shares |
(992) |
(1,017) |
|||
Capital and other reserves |
8,459 |
9,650 |
|||
Retained earnings |
39,155 |
47,065 |
|
||
Total equity - attributable to ordinary shareholders |
65,485 |
74,170 |
|
||
Interim Consolidated Statement of Changes in Equity for the six months to 30 September 2014
|
Share Capital £'000 |
Share premium £'000 |
Own shares £'000 |
Capital reserves £'000 |
Other reserves £'000 |
Retained earnings £'000 |
Total equity £'000 |
As at 1 April 2014 |
2,184 |
16,288 |
(1,017) |
143 |
9,507 |
47,065 |
74,170 |
Profit for the period |
- |
- |
- |
- |
- |
9,079 |
9,079 |
Other comprehensive income |
- |
- |
- |
- |
(320) |
- |
(320) |
Total comprehensive income |
- |
- |
- |
- |
(320) |
9,079 |
8,759 |
Issue of shares against options |
23 |
368 |
25 |
- |
- |
(11) |
405 |
Issue of shares on crystallisation event |
- |
- |
- |
- |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
(18,100) |
(18,100) |
Share based payment |
- |
- |
- |
- |
- |
1,122 |
1,122 |
Current tax in respect of employee share options |
- |
- |
- |
- |
836 |
- |
836 |
Deferred tax in respect of employee share options |
- |
- |
- |
- |
(1,707) |
- |
(1,707) |
As at 30 September 2014 (unaudited) |
2,207 |
16,656 |
(992) |
143 |
8,316 |
39,155 |
65,485 |
|
|
|
|
|
|
|
|
As at 1 April 2013 |
2,062 |
16,094 |
(1,017) |
219 |
3,629 |
32,776 |
53,763 |
Profit for the period |
- |
- |
- |
- |
- |
7,720 |
7,720 |
Other comprehensive income |
- |
- |
- |
- |
1,059 |
- |
1,059 |
Total comprehensive income |
- |
- |
- |
- |
1,059 |
7,720 |
8,779 |
Issue of shares against options |
16 |
58 |
- |
- |
- |
(14) |
60 |
Issue of shares on crystallisation event |
3 |
- |
- |
(3) |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
(8,913) |
(8,913) |
Share based payment |
- |
- |
- |
- |
- |
551 |
551 |
Deferred tax in respect of employee share options |
- |
- |
- |
- |
2,584 |
- |
2,584 |
As at 30 September 2013 (unaudited) |
2,081 |
16,152 |
(1,017) |
216 |
7,272 |
32,120 |
56,824 |
Interim Consolidated Statement of Cash Flow for the six months to 30 September 2014
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
||||
Operating activities |
|
|
||||
Cash (used)/generated from operations |
(8,021) |
5,073 |
||||
Tax paid |
(3,010) |
(2,784) |
||||
Net cash flow from operating activities |
(11,031) |
2,289 |
||||
Investing activities |
|
|
||||
Interest received and similar income |
8 |
8 |
||||
Purchase of property, plant and equipment |
(33) |
(41) |
|
|||
Proceeds from sale of available-for-sale financial assets |
10,271 |
21,226 |
|
|||
Purchase of available-for-sale financial assets |
(6,212) |
(23,279) |
|
|||
Cash flows related to derivatives |
613 |
(28) |
|
|||
Net cash flow from investing activities |
4,647 |
(2,114) |
|
|||
Financing activities |
|
|
|
|||
Dividends paid |
(18,100) |
(8,913) |
|
|||
Issue of ordinary shares |
405 |
74 |
|
|||
Net cash flow from financing activities |
(17,695) |
(8,839) |
|
|||
Net decrease in cash and cash equivalents |
(24,079) |
(8,664) |
|
|||
Cash and cash equivalents at start of period |
47,041 |
30,940 |
|
|||
Cash and cash equivalents at end of period |
22,962 |
22,276 |
|
|||
Notes to the Unaudited Interim Consolidated Financial Statements
For the six months to 30 September 2014
1. General Information, Basis of Preparation and Accounting Policies
Polar Capital Holdings plc ("the Company") is a public limited Company registered in England and Wales.
The unaudited interim condensed consolidated financial statements to 30 September 2014 have been prepared in accordance with IAS 34: Interim Financial Reporting.
The unaudited interim condensed consolidated financial statements do not include all the information and disclosures required in annual financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 March 2014 which have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and the Companies Act 2006 applicable to companies reporting under IFRS.
The accounting policies adopted in the preparation of the unaudited interim condensed consolidated financial statements are consistent with those used in the preparation of the Group's annual financial statements for the year ended 31 March 2014.
2. Revenue
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
Investment management fees |
41,287 |
31,675 |
Investment performance fees |
- |
- |
Profit/(loss) on hedging |
516 |
(29) |
|
41,803 |
31,646 |
3 Profit on Ordinary Activities Before Taxation
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
||
a. Profit on ordinary activities before taxation is stated after charging: |
|
|
||
Staff costs |
18,082 |
14,783 |
||
Depreciation of tangible fixed assets |
36 |
29 |
||
Operating lease rentals - land & buildings |
483 |
392 |
||
Operating lease rentals - other |
606 |
190 |
||
b. Auditors' remuneration: |
|
|
||
Audit of group financial statements |
20 |
20 |
||
Other fees |
|
|
||
|
- local statutory audits of subsidiaries |
15 |
15 |
|
|
- tax services |
- |
- |
|
|
- internal controls review |
22 |
22 |
|
4. Dividends
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
Dividend paid |
18,100 |
8,913 |
5. Earnings Per Ordinary Share
The calculation of basic earnings per ordinary share is based on the profit for the period of £9,078,624 (September 2013: profit £7,719,758); and on 86,077,915 (September 2013:80,975,377) ordinary shares, being the weighted number of ordinary shares.
The calculation of diluted earnings per ordinary share is based on the profit for the period of £9,078,624 (September 2013: profit £7,719,758) and 94,919,336 (September 2013: 94,298,538) ordinary shares, being the weighted average number of ordinary shares allowing for all options of 8,007,244 (September 2013: 9,602,935) which are dilutive as well as shares granted under a crystallisation event but not yet issued of 834,177 (September 2013: 3,720,227).
The calculation of adjusted earnings per ordinary share is based on a profit for the period of £9,078,624 (September 2013: profit of £7,719,758) but adjusted for the share-based payments charge of £1,121,755, (September 2013: share base payments charge of £550,900) and 94,919,336 (September 2013: 94,298,538) ordinary shares being the weighted average number of ordinary shares allowing for all dilutive options and as well as shares granted during the period under a crystallisation event but not yet issued.
6. Available-for-sale Financial Assets
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Audited) Year to 31 March 2014 £'000 |
At beginning of period |
43,912 |
31,246 |
Additions |
6,212 |
65,730 |
Redemptions |
(10,303) |
(52,680) |
Net gain on movement in fair value |
663 |
(384) |
At end of period |
40,484 |
43,912 |
7. Notes to the Cash Flow Statement
Reconciliation of profit before taxation to cash generated from operations
|
(Unaudited) Six months to 30 September 2014 £'000 |
(Unaudited) Six months to 30 September 2013 £'000 |
|||
Cash flows from operating activities |
|
|
|||
Profit on ordinary activities before tax |
11,592 |
10,085 |
|||
Interest received |
(7) |
(8) |
|||
Depreciation of tangible fixed assets |
36 |
29 |
|||
Increase in trade and other receivables |
(6,932) |
(420) |
|||
Decrease in trade and other payables |
(14,537) |
(4,751) |
|||
Loss/(gain) on disposal of available-for-sale financial assets |
33 |
(850) |
|||
Loss on instruments at fair value through profit or loss |
875 |
637 |
|||
Gain on derivatives |
(203) |
(200) |
|||
Share-based payment |
1,122 |
551 |
|||
|
Cash (used)/generated from operations |
(8,021) |
5,073 |
||
8. Related Party Transactions
Transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not included in this note.
B J D Ashford-Russell is a member of Polar Capital LLP and a director of the Polar Capital Technology Trust plc (the Trust). Polar Capital LLP is the appointed investment manager of the Trust. The total fees received by the Group as investment manager of the Trust were £3,237,883 (September 2013: £2,816,851). The amounts receivable at period end in this respect were £1,127,841 (March 2014: £1,072,600).
At the end of the period, the Group had an outstanding loan due of £992,251 (March 2014: £1,017,131) from the Polar Capital Employee Benefit Trust, which was set up in 2002 to hold ordinary shares in Polar Capital Holdings plc for the benefit of employees.
9. The Publication of Non-Statutory Accounts
The financial information contained in this unaudited half year report does not constitute statutory accounts as defined in S434 of the Companies Act 2006. The financial information for the six months ended 30 September 2014 and 2013 has not been audited. The information for the year ended 31 March 2014 has been extracted from the latest published audited accounts, which have been filed with the Registrar of Companies. The audited accounts filed with the Registrar of Companies contain a report of the independent auditor dated 19 June 2014. The report of the independent auditor on those financial statements contained no qualification or statement under S498 of the Companies Act 2006.
Directors
T H Bartlam |
Non-executive Chairman |
T J Woolley |
Chief Executive Officer |
J B Mansell |
Chief Operating Officer |
H G C Aldous |
Non-executive Director, Chairman of Audit Committee |
B J D Ashford-Russell |
Non-executive Director |
G V Bumeder |
Non-executive Director |
J M B Cayzer-Colvin |
Non-executive Director |
M W Thomas |
Non-executive Director, Chairman of Remuneration Committee |
Dividend
A first interim dividend of 5.5p per share has been declared for the year to 31 March 2015. This will be paid on 16 January 2015 to shareholders on the register on 30 December 2014. The shares will trade ex-dividend from 29 December 2014.
Remuneration Code
Disclosure of the group's Remuneration Code will be made along side its Pillar 3 disclosure which is available on the Company's website
Nominated Advisor and Corporate Broker to the Company
Canaccord Genuity
Half Year Report
The Half Year report will be posted to shareholders in late December 2014. Copies of this announcement and of the Half Year report will be available from the Secretary at the Registered Office, 4 Matthew Parker Street, London SW1H 9NP and from the Company's website at www.polarcapital.co.uk
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.
ENDS